Literature DB >> 7285840

Fatty acid utilization in perinatal de novo synthesis of tissues.

M T Clandinin, J E Chappell, T Heim, P R Swyer, G W Chance.   

Abstract

The fatty acid content of fetal tissues was utilized to estimate essential fatty acid accretion during intrauterine growth. These rates of essential fatty acid accretion were used to predict that 400 mg/kg of body weight for omega-6 fatty acids and 50 mg/kg of body weight for omega-3 fatty acids per day would be used for intrauterine de novo synthesis of tissues. For the high risk low birth weight infant of approx. 1300 g birthweight it can be calculated that extrauterine de novo tissue synthesis would utilize about 280 mg/kg of body weight for omega-6 fatty acids and about 35 mg/kg of body weight for omega-3 fatty acids based on projected growth rates that are similar in composition to intrauterine growth and amount to 17 g of gain per day. From fatty acid analysis of brown and white adipose tissue it was estimated that some 70 and 78% of these net whole body accretion rates for essential fatty acids represent omega-6 and omega-3 fatty acid accretion in the adipose organs. Fatty acid analysis of human milk at day 16 of lactation was utilized to estimate the low birth weight infants' daily intake of major essential and other fatty acids. For intake levels of 120 kcal/kg it was concluded that the essential fatty acid content of mothers' own milk provides 6650 +/- 345 mg of total fatty acids, 850 +/- 160 mg of omega-6 fatty acids and 140 +/- 17 mg of omega-3 fatty acids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285840     DOI: 10.1016/0378-3782(81)90016-5

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  44 in total

Review 1.  Brain development and assessing the supply of polyunsaturated fatty acid.

Authors:  M T Clandinin
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

2.  Recommend omega-3 fatty acids in pregnancy?

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

3.  Choline and polyunsaturated fatty acids in preterm infants' maternal milk.

Authors:  Christoph Maas; Axel R Franz; Anna Shunova; Michaela Mathes; Christine Bleeker; Christian F Poets; Erwin Schleicher; Wolfgang Bernhard
Journal:  Eur J Nutr       Date:  2016-05-10       Impact factor: 5.614

4.  Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy.

Authors:  W E Connor; R Lowensohn; L Hatcher
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

5.  High dietary 18:3n-3 increases the 18:3n-3 but not the 22:6n-3 content in the whole body, brain, skin, epididymal fat pads, and muscles of suckling rat pups.

Authors:  R A Bowen; M T Clandinin
Journal:  Lipids       Date:  2000-04       Impact factor: 1.880

Review 6.  Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status.

Authors:  Lotte Lauritzen; Susan E Carlson
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

7.  Maternal dietary fat affects milk fatty acid profile and impacts on weight gain and thermogenic capacity of suckling rats.

Authors:  Teresa Priego; Juana Sánchez; Ana Paula García; Andreu Palou; Catalina Picó
Journal:  Lipids       Date:  2013-02-16       Impact factor: 1.880

8.  Omega-3 Fatty Acid supplementation during pregnancy.

Authors:  James A Greenberg; Stacey J Bell; Wendy Van Ausdal
Journal:  Rev Obstet Gynecol       Date:  2008

9.  Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial.

Authors:  J S Forsyth; P Willatts; C Agostoni; J Bissenden; P Casaer; G Boehm
Journal:  BMJ       Date:  2003-05-03

10.  Fatty acid patterns early after premature birth, simultaneously analysed in mothers' food, breast milk and serum phospholipids of mothers and infants.

Authors:  Karl-Göran Sabel; Cristina Lundqvist-Persson; Elsa Bona; Max Petzold; Birgitta Strandvik
Journal:  Lipids Health Dis       Date:  2009-06-10       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.